LSV Associates LLC 13D and 13G filings for ALX Oncology Holdings Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2024-02-14 7:28 pm Sale | 2023-12-15 | 13D | ALX Oncology Holdings Inc. ALXO | LSV Associates LLC | 2,949,580 5.900% | -1,259,395 (-29.92%) | Filing |
| 2023-12-19 5:38 pm Sale | 2023-12-13 | 13D | ALX Oncology Holdings Inc. ALXO | LSV Associates LLC | 4,208,975 8.400% | -512,015 (-10.85%) | Filing |
| 2020-07-30 9:53 pm Purchase | 2020-07-21 | 13D | ALX Oncology Holdings Inc. ALXO | LSV Associates LLC | 4,720,990 12.900% | 4,720,990 (New Position) | Filing |